Latest Ratios: P/E Ratio -0.6x · EV/EBITDA N/A · ROE -145.7%. (2018–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $164M | $61M | $87M | $640M | $459M | $866M | $3.4B | — | — |
| Enterprise Value | $153M | $49M | $87M | $635M | $420M | $503M | $3.0B | — | — |
| P/E Ratio → | -0.64 | — | — | — | — | — | — | — | — |
| P/S Ratio | — | — | — | — | — | — | 2905.75 | — | — |
| P/B Ratio | 2.52 | 2.33 | 0.77 | 3.37 | 1.74 | 2.39 | 7.99 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | — | 2538.39 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | 9.1% | 9.1% | 9.0% |
| Operating Margin | — | — | — | — | — | — | -3694.0% | -400.0% | -662.0% |
| Net Profit Margin | — | — | — | — | — | — | -3869.7% | -401.2% | -664.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -145.7% | -145.7% | -88.9% | -71.0% | -39.4% | -21.1% | -21.3% | -433.4% | -150.0% |
| ROA | -98.3% | -98.3% | -69.1% | -58.6% | -36.0% | -20.5% | -20.5% | -176.2% | -123.0% |
| ROIC | -122.0% | -122.0% | -71.8% | -62.4% | -84.9% | -50537.3% | — | — | -1149.3% |
| ROCE | -127.0% | -127.0% | -84.8% | -70.3% | -39.6% | -21.0% | -20.1% | -256.1% | -147.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.20 | 0.20 | 0.15 | 0.09 | 0.04 | 0.00 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.43 | -0.01 | -0.03 | -0.15 | -1.00 | -1.01 | — | -0.90 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -62.48 | -62.48 | -76.99 | -101.75 | -517.56 | -6420.85 | -53.84 | -913.71 | — |
Net cash position: cash ($16M) exceeds total debt ($5M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.07 | 2.07 | 7.26 | 5.24 | 9.57 | 24.00 | 70.28 | 1.97 | 5.45 |
| Quick Ratio | 2.07 | 2.07 | 7.26 | 5.24 | 9.57 | 24.00 | 70.28 | 1.97 | 5.45 |
| Cash Ratio | 1.82 | 1.82 | 6.91 | 5.08 | 9.40 | 23.78 | 69.99 | 1.81 | 4.41 |
| Asset Turnover | — | — | — | — | — | — | 0.00 | 0.45 | 0.19 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | 40.79 | 164.58 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $54M | $52M | $43M | $41M | $40M | $40M | $22M | $22M |
Includes 30+ ratios · 8 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ALXO stock.
ALX Oncology Holdings Inc.'s current P/E ratio is -0.6x. This places it at the 50th percentile of its historical range.
ALX Oncology Holdings Inc.'s return on equity (ROE) is -145.7%. The historical average is -121.3%.
Based on historical data, ALX Oncology Holdings Inc. is trading at a P/E of -0.6x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.